Santhera Pharmaceuticals Holding(SPHDF)
$18.300.00 (0.00%)
SPHDF
Santhera Pharmaceuticals Holding financials statements
$18.30
At close:0.00 (0.00%)
Santhera Pharmaceuticals Holding (SPHDF) Income Statement
40 Followers
Santhera Pharmaceuticals Holding Income Statement
Last quarter (Q2 2026), Santhera Pharmaceuticals Holding's total revenue was CHF48.33M, an increase of 242.43% from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was CHF-21.53M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| CHF 77.19M | CHF 39.12M | CHF 103.41M | CHF 7.47M | CHF -1.59M | |
| CHF 14.47M | CHF 22.96M | CHF 100.18M | CHF 3.88M | CHF -5.36M | |
| CHF 52.28M | CHF 56.69M | CHF 31.34M | CHF 55.86M | CHF 51.53M | |
| Depreciation and Amortization | CHF 5.69M | CHF 5.65M | CHF 3.04M | CHF 3.65M | CHF 3.72M |
| CHF -32.13M | CHF -15.89M | CHF 79.17M | CHF -46.78M | CHF -34.57M | |
| CHF -37.82M | CHF -33.38M | CHF 68.84M | CHF -51.98M | CHF -56.89M | |
| CHF -11.23M | CHF -8.28M | CHF -14.02M | CHF -18.64M | CHF 2.17M | |
| CHF -49.05M | CHF -41.66M | CHF 54.82M | CHF -70.62M | CHF -54.72M | |
| CHF -49.24M | CHF -41.97M | CHF 54.78M | CHF -71.08M | CHF -55.53M | |
| Per Share Metrics | |||||
| Basic EPS | CHF -3.78 | CHF -3.69 | CHF 5.18 | CHF -11.67 | CHF -16.25 |
| Diluted EPS | CHF -3.78 | CHF -3.69 | CHF 5.01 | CHF -11.67 | CHF -16.25 |
| Weighted Average Shares Outstanding | 13.01M | 11.38M | 10.58M | 6.09M | 3.42M |
| Weighted Average Shares Outstanding (Diluted) | 13.01M | 11.38M | 10.92M | 6.09M | 3.42M |
Currency in CHF
